- Home
- PLNT vs ITCI Comparison
PLNT vs ITCI Comparison
Compare PLNT & ITCI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PLNT
- ITCI
- Stock Information
- Founded
- PLNT 1992
- ITCI 2002
- Country
- PLNT United States
- ITCI United States
- Employees
- PLNT N/A
- ITCI N/A
- Industry
- PLNT Hotels/Resorts
- ITCI Biotechnology: Pharmaceutical Preparations
- Sector
- PLNT Consumer Discretionary
- ITCI Health Care
- Exchange
- PLNT Nasdaq
- ITCI Nasdaq
- Market Cap
- PLNT 6.9B
- ITCI 8.0B
- IPO Year
- PLNT 2015
- ITCI N/A
- Fundamental
- Price
- PLNT $100.02
- ITCI $85.45
- Analyst Decision
- PLNT Buy
- ITCI Strong Buy
- Analyst Count
- PLNT 17
- ITCI 12
- Target Price
- PLNT $89.47
- ITCI $97.67
- AVG Volume (30 Days)
- PLNT 1.4M
- ITCI 760.7K
- Earning Date
- PLNT 11-07-2024
- ITCI 10-30-2024
- Dividend Yield
- PLNT N/A
- ITCI N/A
- EPS Growth
- PLNT 15.44
- ITCI N/A
- EPS
- PLNT 1.86
- ITCI N/A
- Revenue
- PLNT $1,049,214,000.00
- ITCI $613,728,000.00
- Revenue This Year
- PLNT $24.44
- ITCI $48.25
- Revenue Next Year
- PLNT $10.35
- ITCI $38.47
- P/E Ratio
- PLNT $53.77
- ITCI N/A
- Revenue Growth
- PLNT 4.90
- ITCI 46.08
- 52 Week Low
- PLNT $54.35
- ITCI $58.14
- 52 Week High
- PLNT $100.63
- ITCI $93.45
- Technical
- Relative Strength Index (RSI)
- PLNT 78.57
- ITCI 55.65
- Support Level
- PLNT $94.44
- ITCI $81.83
- Resistance Level
- PLNT $97.34
- ITCI $86.36
- Average True Range (ATR)
- PLNT 2.94
- ITCI 2.54
- MACD
- PLNT 1.00
- ITCI -0.76
- Stochastic Oscillator
- PLNT 97.33
- ITCI 31.15
About PLNT Planet Fitness Inc.
Planet Fitness Inc is a franchisor and operator of fitness centers in the United States. The company's reportable segments are Franchise, Corporate-owned stores, and Equipment. Franchise segment includes operations related to its franchising business in the United States, Puerto Rico, Canada, Panama, Mexico and Australia, Corporate-owned stores segment includes operations with respect to all corporate-owned stores throughout the United States and Canada, and The Equipment segment includes the sale of equipment to franchisee-owned stores in the U.S. The firm generates a majority of its revenue from the Corporate-owned stores segment.
About ITCI Intra-Cellular Therapies Inc.
Intra-Cellular Therapies Inc is a biopharmaceutical company that develops novel drugs for treating diseases of the central nervous system. The company is focused on the delivery and clinical development of small-molecule drugs that address needs in neuropsychiatric and neurological disorders. Intra-Cellular maintains proprietary chemistry platforms to develop drugs for neurodegenerative diseases. The company's business segment is discovering and developing drugs for the treatment of neurological and psychiatric disorders.